Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TVGN stock hub

Tevogen Bio Holdings Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TVGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TVGN

In the news

Latest news · TVGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROEn/a

P25 -106.6P50 -46.9P75 -3.1

ROICn/a

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TVGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

158

Groups with data

Currency

USD

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001860871
Company name	Tevogen Bio Holdings Inc.
Country	United States
Country code	US
Cusip	88165K200
Employees	18
Enterprise value	$38.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US88165K2006
Last refreshed	2026-05-10
Market cap	$31.1M
Market cap category	Nano-Cap
Price	$7.48
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	TVGN
Website	https://tevogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-86.12%
FCF yield	-39.79%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-26.8M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-416.5
ROCE	973.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-85.63%
Cagr3y	-75.95%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4.4M
Cash	$552,372
Current Assets	$1.5M
Current Liabilities	$7.1M
Debt	$7.5M
Equity	$-8.2M
Interest Coverage	-133.6
Liabilities	$12.6M
Long Term Assets	$2.8M
Long Term Liabilities	$5.5M
Net Cash	$-6.9M
Net Cash By Market Cap	$-22.31
Tangible Book Value	$-17M
Tangible Book Value Per Share	$-4.24
WACC	4.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.22
Net Working Capital	$-4.1M
Quick ratio	0.1
Working Capital	$-5.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-85.62%
200-day SMA	23.86
3Y total return	-98.61%
50-day SMA	6.71
50-day SMA vs 200-day SMA	50under200
All Time High	1,054.5
All Time High Change	-99.29%
All Time High Date	2024-02-15
All Time Low	4.14
All Time Low Change	80.89%
All Time Low Date	2026-03-30
ATR	0.72
Beta	0.11
Beta1y	2.47
Beta2y	1.29
Ch YTD	-54.82
High	7.5
High52	75.5
High52 Date	2025-06-06
High52ch	-90.09%
Low	7
Low52	4.14
Low52 Date	2026-03-30
Low52ch	80.9%
Ma50ch	11.51%
Price vs 200-day SMA	-68.65%
RSI	54.84
RSI Monthly	28.59
RSI Weekly	29.6
Sharpe ratio	-1.68x
Sortino ratio	-2.15
Total Return	-13.17%
Tr YTD	-54.82
Tr1m	50.2%
Tr1w	12.31%
Tr3m	-45.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Hold
Earnings EPS Estimate	$-2.5
Operating Income	$-26.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,058,349%
Float Percent	25.42%
Net Borrowing	3,400,000
Shares Insiders	74.58%
Shares Institutions	10.04%
Shares Out	4,164,205
Shares Qo Q	-47.61%
Shares Yo Y	13.17%
Short Float	8.62%
Short Ratio	2.77
Short Shares	2.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-28.6M
Average Volume	18,565.7x
Bv Per Share	-4.24
CAPEX	$-64,439
Ch1m	50.2
Ch1w	12.31
Ch1y	-85.62
Ch3m	-45.52
Ch3y	-98.61
Ch6m	-70.03
Change	0%
Change From Open	-0.27
Close	7.48
Days Gap	0.27
Depreciation Amortization	190,573
Dollar Volume	66,118.8
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-26.1M
EBITDA	$-25.9M
EPS	$-8.08
F Score	1
FCF	$-12.4M
FCF EV Yield	-32.53x
FCF Per Share	$-2.98
Financing CF	11,662,393
Fiscal Year End	December
Founded	2,020
Investing CF	-64,439
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2026-03-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	16.73
Ma150ch	-55.3%
Ma20	7.07
Ma20ch	5.78%
Net CF	-730,623
Next Earnings Date	2026-05-22
Open	7.5
Optionable	No
Position In Range	96
Ppne	1,593,781
Price Date	2026-05-08
Relative Volume	0.48x
Share Based Comp	16,222,861
Tr6m	-70.03%
Us State	New Jersey
Volume	8,839.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TVGN pay a dividend?

Capital-return profile for this ticker.

Performance

TVGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TVGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.0%

Float: +25.4% of shares outstanding

Insider ownership

+74.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TVGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.8

Neutral momentum band

Price vs 200-day MA

-68.7%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

-1.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TVGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TVGN stock rating?

Tevogen Bio Holdings Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TVGN analysis?

The full report lives at /stocks/TVGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TVGN?

The latest report frames TVGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TVGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.